Source: Eur Respir Monogr 2018; 82: 179-204
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Maria Krutikov, Judith Bruchfeld, Giovanni Battista Migliori, Sergey Borisov, Simon Tiberi. New and repurposed drugs. Eur Respir Monogr 2018; 82: 179-204

Member's Comments

No comment yet.

Related content which might interest you: New and repurposed drugs for MDR-TB patients Source: International Congress 2017 – PG2 Multidrug-resistant tuberculosis management in settings with a low tuberculosis incidence  Year: 2017 New twists in the pharmacology of NSAID drugs Source: Annual Congress 2007 - Recent advances in our understanding of the mechanisms of asthma treatment Year: 2007 New and repurposed TB drugs use in children and adolescents with M/XDR-TB Source: International Congress 2017 – Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now? Year: 2017 New therapeutic targets Source: Annual Congress 2007 - COPD – a disease of accelerated ageing? Year: 2007 New anti-tuberculosis drugs for special populations: a difficult-to-address issue Source: Eur Respir J 2016; 48: 957-958 Year: 2016 New antibiotic development for pulmonary infections: New Drugs for Bad Bugs and beyond Source: Eur Respir Monogr 2017; 75: 289-301 Year: 2017 New anti-tuberculosis drugs and regimens: 2015 update Source: ERJ Open Res 2015; 1: 00010-2015 Year: 2015 New targets for drug development in asthma Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008 Prospects for new compounds tiosemikarbazonami class to create drugs with antituberculosis activity Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014 Anti-tuberculosis drugs Source: International Congress 2017 – State of the art session: "Respiratory infections" Year: 2017 New methodologogic approaches to the management of antituberculous service Source: Eur Respir J 2003; 22: Suppl. 45, 381s Year: 2003 New therapeutic strategies in BOS Source: Annual Congress 2007 - Bronchiolitis obliterans syndrome (BOS) after lung transplantation: new kids on the block Year: 2007 Perspectives on the new drugs pipeline Source: School Course 13 Year: 2013 Facts and perspectives in the development of new anti-TB drugs Source: Annual Congress 2008 - New insights into tuberculosis control Year: 2008 New drugs for severe asthma – what should we target and how? Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014